Patent ID: 7192928

Claim:
A peptide that inhibits T-cell antigen receptor (TCR function, which has a formula selected from the group consisting of formula NH2-Ile-Leu-Leu-Leu-Lys-Val-Ala-Gly-Phe-OH (SEQ ID NO. 6), NH2-Ile-Leu-Leu-Leu-Lys-Val-Ala-Gly-OH (SEQ ID NO. 7), NH2-Leu-Arg-Ile-Leu-Leu-Leu-Gly-Val-OH (SEQ ID NO. 8), NH2-Leu-Gly-Ile-Leu-Leu-Leu-Lys-Val-OH (SEQ ID NO. 9), NH2-Ile-Leu-Leu-Gly-Lys-Ala-Thr-Leu-Tyr-OH (SEQ ID NO. 10), NH2-Met-Gly-Leu-Arg-Ile-Leu-Leu-Leu-OH (SEQ ID NO. 11), NH2-Leu-Leu-Met-Thr-Leu-Arg-Leu-Trp-Ser-Ser-COOH (SEQ ID NO. 12) NH2-Ile-Ile-Val-Thr-Asp-Val-Ile-Ala-Thr-Leu-OH (SEQ ID NO. 13) NH2-Ile-Val-Ile-Val-Asp-Ile-Cys-Ile-Thr-OH (SEQ ID NO. 14), NH2-Phe-Leu-Phe-Ala-Glu-Ile-Val-Ser-Ile-OH (SEQ ID NO. 15) NH2-Ala-Gly-Phe-Asn-Leu-Leu-Met-Thr-COOH (SEQ ID NO. 16).